Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients

Journal of Diabetes Research
Vendula BartákováKateřina Kaňková

Abstract

Elevated resting heart rate (RHR) has been associated with increased risk of mortality and cardiovascular events. Limited data are available so far in type 2 diabetic (T2DM) subjects with no study focusing on progressive renal decline specifically. Aims of our study were to verify RHR as a simple and reliable predictor of adverse disease outcomes in T2DM patients. A total of 421 T2DM patients with variable baseline stage of diabetic kidney disease (DKD) were prospectively followed. A history of the cardiovascular disease was present in 81 (19.2%) patients at baseline, and DKD (glomerular filtration rate < 60 mL/min or proteinuria) was present in 328 (77.9%) at baseline. Progressive renal decline was defined as a continuous rate of glomerular filtration rate loss ≥ 3.3% per year. Resting heart rate was not significantly higher in subjects with cardiovascular disease or DKD at baseline compared to those without. Using time-to-event analyses, significant differences in the cumulative incidence of the studied outcomes, that is, progression of DKD (and specifically progressive renal decline), major advanced cardiovascular event, and all-cause mortality, between RHR </≥65 (arbitrary cut-off) and 75 (median) bpm were not found. We did...Continue Reading

References

Apr 1, 1985·Journal of the American Geriatrics Society·R D LindemanN W Shock
Feb 5, 2000·Journal of Hypertension·J F MorcetA Benetos
Apr 30, 2003·Diabetes Care·Aaron I VinikRoy Freeman
Jul 8, 2003·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·B Linnemann, H U Janka
Feb 11, 2005·Clinical and Experimental Hypertension : CHE·P Palatini, S Julius
Aug 28, 2007·Journal of the American College of Cardiology·Kim FoxUNKNOWN Heart Rate Working Group
Jan 10, 2008·Diabetes Care·UNKNOWN American Diabetes Association
Jul 21, 2009·Progress in Cardiovascular Diseases·Paolo Palatini
Nov 4, 2010·Nature Reviews. Nephrology·Takahiko NakagawaQiuhong Li
Jun 22, 2012·European Journal of Preventive Cardiology·Mark WoodwardUNKNOWN from the Asia Pacific Cohort Studies Collaboration
Jan 15, 2013·Journal of the American Heart Association·Graham S HillisJohn Chalmers
Nov 13, 2013·Clinical and Experimental Nephrology·Andrzej S KrolewskiMonika A Niewczas
May 2, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·G PuglieseUNKNOWN RIACE Study Group

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
urine collection

Software Mentioned

Statistica

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.